WallStreetZenWallStreetZen

NASDAQ: HHS
Harte Hanks Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Harte Hanks revenue was $185.24M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $47.1M, down 1.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, HHS annual revenue was $185.2M, with -3.3% growth year-over-year.

HHS past revenue growth

How has HHS's revenue growth performed historically?

Company
-3.26%
Industry
2%
Market
20.87%
HHS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
HHS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
HHS's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

HHS revenue history

Current Revenue
$185.2M
Current Earnings
-$30.3M
Current Profit Margin
-16.4%

Be the first to know when HHS announces revenue.

HHS Revenue History By Year

HHS Yearly RevenueHHS RevenueHHS ChangeHHS Revenue Growth
2024-12-31$185.24M-$6.25M-3.26%
2023-12-31$191.49M-$14.79M-7.17%
2022-12-31$206.28M$11.68M+6.00%
2021-12-31$194.60M$17.70M+10.00%
2020-12-31$176.90M-$40.68M-18.70%
2019-12-31$217.58M-$67.05M-23.56%
2018-12-31$284.63M-$99.28M-25.86%
2017-12-31$383.91M-$20.51M-5.07%
2016-12-31$404.41M-$39.75M-8.95%
2015-12-31$444.17M-$55.28M-11.07%
2014-12-31$499.44M-$60.17M-10.75%
2013-12-31$559.61M-$21.48M-3.70%
2012-12-31$581.09M-$33.18M-5.40%
2011-12-31$614.27M-$206.45M-25.15%
2010-12-31$820.72M-$39.42M-4.58%
2009-12-31$860.14M-$222.68M-20.56%
2008-12-31$1.08B-$80.07M-6.89%
2007-12-31$1.16B-$21.80M-1.84%
2006-12-31$1.18B$49.70M+4.38%
2005-12-31$1.13B$104.53M+10.14%
2004-12-31$1.03B$85.89M+9.09%
2003-12-31$944.58M$35.80M+3.94%
2002-12-31$908.78M-$9.15M-1.00%
2001-12-31$917.93M-$42.85M-4.46%
2000-12-31$960.77M$131.02M+15.79%
1999-12-31$829.75M$81.21M+10.85%
1998-12-31$748.55M$110.20M+17.26%
1997-12-31$638.35M$122.89M+23.84%
1996-12-31$515.46M$62.16M+13.71%
1995-12-31$453.30M-$126.30M-21.79%
1994-12-31$579.60MN/AN/A

1 of 3

Harte Hanks Revenue FAQ

What was HHS's revenue last quarter?

On Invalid Date, Harte Hanks (NASDAQ: HHS) reported Q4 2024 revenue of $47.13 million up 4.77% year over year. In the same quarter last year, Harte Hanks's revenue was $49.49 million.

What was Harte Hanks's revenue in 2024?

Harte Hanks's annual revenue for the twelve months ending Dec 31, 2024 was $185.24 million, a 3.26% decrease year over year.

How much does Harte Hanks make in a day?

Based on Harte Hanks annual revenue for the past five years, HHS makes an average of $523,018.08 per day.

What was Harte Hanks's annual revenue growth in the past year?

As of Q2 2025, Harte Hanks's revenue has grown -3.26% year over year. This is 5.26 percentage points lower than the US Conglomerates industry revenue growth rate of 2%. Harte Hanks's revenue in the past year totaled $185.24 million.

How much does Harte Hanks make in a year?

Harte Hanks's revenue by year for the past five years is:
  • Harte Hanks's revenue for the twelve months ending Dec 31, 2024 was $185.24 million, a 3.26% decrease year over year.
  • Harte Hanks's annual revenue for Dec 31, 2023 was $191.49 million, a 7.17% decrease from 2022.
  • Harte Hanks's annual revenue for 2022 was $206.28 million, a 6% increase from 2021.
  • Harte Hanks's annual revenue for 2021 was $194.60 million, a 10% increase from 2020.
  • Harte Hanks's annual revenue for 2020 was $176.90 million, a 18.7% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.